$Recombinant activated factor VIIa treatment for refractory hemorrhage in infants$

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants

Objective: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. Study Design: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematological data and volume of blood transfusions befo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perinatology 2011-03, Vol.31 (3), p.188-192
Hauptverfasser:	Dang, C N, Katakam, L I, Smith, P B, Cotten, C M, Goldberg, R N, Chandler, N, Thornburg, C D, Bidegain, M
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/436/2388 631/154/51/2314 692/699/75/593 692/700/1720 Birth weight Bleeding Blood coagulation factors Blood Transfusion Care and treatment Coagulation Coagulation factor VIIa Dosage Dosage and administration Factor VIIa - administration & dosage Female Gestational Age Hemorrhage Hemorrhage - drug therapy Hemostasis Hemostatics Humans Infant, Newborn Infants Infants (Newborn) Intensive care units Male Medicine Medicine & Public Health Mortality Neonates original-article Pediatric Surgery Pediatrics Physiological aspects Prothrombin Recombinant Proteins - administration & dosage Recurrence Retrospective Studies Risk factors Thrombin Thromboembolism Thromboplastin Thrombosis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!